Abstract
Since left heart bypass or biventricular circulatory assist with an extracorporeal centrifugal pump as a bridge to decision or recovery sometimes requires long-time support, the long-term durability of extracorporeal centrifugal pumps is crucial. The Rotaflow Centrifugal Pump® (MAQUET Cardiopulmonary AG, Hirrlingen, Germany) is one of the centrifugal pumps available for long-term use in Japan. However, there have been few reports of left heart bypass or biventricular circulatory support over the mid-term. This is a case report of left heart bypass support with the Rotaflow Centrifugal Pump® as a bridge to decision and recovery for an adult patient who could not be weaned from cardiopulmonary bypass and percutaneous cardiopulmonary support after cardiac surgery. We could confirm that the patient’s consciousness level was normal; however, the patient could not be weaned from the left heart bypass support lasting 1 month. Therefore, the circulatory assist device was switched to the extracorporeal Nipro ventricular assist device (VAD). This time, left heart bypass support could be maintained for 30 days using a single Rotaflow Centrifugal Pump®. There were no signs of hemolysis during left heart bypass support. The Rotaflow Centrifugal Pump® itself may be used as a device for a bridge to decision or recovery before using a VAD in cardiogenic shock patients.
References
John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ, Frazier OH, Joyce LD. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932–9.
Gerrah R, Charette K, Chen JM. The first successful use of the Levitronix PediMag ventricular support device as a biventricular bridge to transplant in an infant. J Thorac Cardiovasc Surg. 2011;142:1282–3.
Takayama H, Chen JM, Jorde UP, Naka Y. Implantation technique of the CentriMag biventricular assist device allowing ambulatory rehabilitation. Interact Cardiovasc Thorac Surg. 2011;12:110–1.
Mendler N, Podechtl F, Feil G, Hiltmann P, Sebening F. Seal-less centrifugal blood pump with magnetically suspended rotor: rot-a-flot. Artif Organs. 1995;19:620–4.
Sato M, Kashiwabara S, Tanaka H, Tatsumi E, Takeno H. In vitro antithrombogenic evaluation of newly developed heparinized material. J Artif Organs. 1999;28:502–8.
Nishinaka T, Tatsumi T, Katagiri N, Ohnishi H, Mizuno T, Shioya K, Tsukiya T, Homma A, Kashiwabara S, Tanaka H, Sato M, Taenaka Y. Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a long-term durable antithrombogenic coating to a combination of a seal-less centrifugal pump and a diffusion membrane oxygenator. J Artif Organs. 2007;10:240–4.
Inoue T, Nishimura T, Murakami A, Itatani K, Takaoka T, Kitahori K, Umeki A, Takezoe T, Kashiwa K, Kyo S, Ono M. Left ventricular assist device support with a centrifugal pump for 2 months in a 5-kg child. J Artif Organs. 2011;14:253–6.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kashiwa, K., Nishimura, T., Saito, A. et al. Left heart bypass support with the Rotaflow Centrifugal Pump® as a bridge to decision and recovery in an adult. J Artif Organs 15, 207–210 (2012). https://doi.org/10.1007/s10047-012-0632-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-012-0632-x